title: Flipping the phenotypic switch on a novel antimelanoma differentiation strategy.
authors.forename: Willie
authors.initials: W
authors.lastname: Wilson
authors.forename: Glenn
authors.initials: G
authors.lastname: Merlino
mesh_terms: D000818:Animals; D002392:Catechin / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D002454:Cell Differentiation / Q000187:drug effects; D045744:Cell Line, Tumor; D006801:Humans; D008544:Melanocytes / Q000187:drug effects / Q000473:pathology; D008545:Melanoma / Q000188:drug therapy / Q000201:enzymology / Q000473:pathology*; D008727:Methotrexate / Q000494:pharmacology / Q000627:therapeutic use; D051379:Mice; D051739:Microphthalmia-Associated Transcription Factor / Q000378:metabolism; D014442:Monophenol Monooxygenase / Q000378:metabolism; D010641:Phenotype
chemical_list: C529447:3-O-(3,4,5-trimethoxybenzoyl)epicatechin; D051739:Microphthalmia-Associated Transcription Factor; D002392:Catechin; D014442:Monophenol Monooxygenase; D008727:Methotrexate